Adlai Nortye ANL
NASDAQ ANL
$15.01 +0.26 (+1.76%)
At close: Sep 4, 2026 · 4:00 PM EDT

Adlai Nortye (ANL) Accumulated Expenses (2022 - 2026)

Adlai Nortye (ANL) posted quarterly Accumulated Expenses of $3.1 million for Q4 2025, up 2.64% year-over-year from $3.1 million in Q4 2024, and down 35.56% quarter-over-quarter from $4.9 million in Q2 2025.

Analysis

Adlai Nortye (ANL) Accumulated Expenses (2022 - 2026) Analysis & Trends

Adlai Nortye (ANL) has reported Accumulated Expenses for 4 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accumulated Expenses rose 2.64% year-over-year to $3.1 million; the TTM figure through Dec 2025 stood at $3.1 million (up 2.64% YoY), while the FY2025 annual figure was $3.1 million, up 2.64% from the prior year.
  • Accumulated Expenses slipped to $3.1 million in Q4 2025 per ANL's latest filing, from $4.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $4.9 million in Q2 2025 and bottomed at $3.1 million in Q4 2024.
  • Historically, Accumulated Expenses has averaged $3.7 million across 4 years, with a median of $3.7 million in 2022.
  • Annual changes were most pronounced in 2024 — Accumulated Expenses declined 19.69% — and 2025, when it gained 28.73%.
  • Adlai Nortye's Accumulated Expenses stood at $3.6 million in 2022, then increased by 5.3% to $3.8 million in 2023, then retreated by 19.69% to $3.1 million in 2024, then increased by 2.64% to $3.1 million in 2025.
  • Business Quant data shows ANL's Accumulated Expenses at $3.1 million in Q4 2025, $4.9 million in Q2 2025, and $3.1 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adlai Nortye 500.08 Mn 268.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.22 Mn
Dec 31, 2025 3.74 Mn
Jun 30, 2025 4.88 Mn
Dec 31, 2024 3.41 Mn
Jun 30, 2024 3.79 Mn
Dec 31, 2023 4.25 Mn
Dec 31, 2022 3.88 Mn